Evidence map›Paper›PMID 41511369›Full record

ArticleCells2026

Evidence for Quasi-High-LET Biological Effects in Clinical Proton Beams That Suppress c-NHEJ and Enhance HR and Alt-EJ.

Emil Mladenov, Mina Pressler, Veronika Mladenova, Aashish Soni, Fanghua Li, Feline Heinzelmann, Johannes Niklas Esser, Razan Hessenow, Eleni Gkika, Verena Jendrossek and 3 more

Abstract read
In one paragraph

Article in Cells, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Emil MladenovDepartment of Radiation Therapy, Division of Experimental Radiation Biology, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.
Mina PresslerInstitute of Medical Radiation Biology, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.
Veronika MladenovaDepartment of Radiation Therapy, Division of Experimental Radiation Biology, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.
Aashish SoniDepartment of Radiation Therapy, Division of Experimental Radiation Biology, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.ORCID 0000-0001-9696-1006
Fanghua LiInstitute of Medical Radiation Biology, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.ORCID 0000-0001-7610-8489
Feline HeinzelmannWestdeutsches Protonentherapiezentrum Essen, University Hospital Essen, 45147 Essen, Germany.
Johannes Niklas EsserWestdeutsches Protonentherapiezentrum Essen, University Hospital Essen, 45147 Essen, Germany.
Razan HessenowWestdeutsches Protonentherapiezentrum Essen, University Hospital Essen, 45147 Essen, Germany.ORCID 0009-0002-1488-8103
Eleni GkikaRadiation Biology Laboratory, Department of Radiotherapy and Radiation Oncology, University Hospital Bonn, 53127 Bonn, Germany.
Verena JendrossekInstitute of Cell Biology (Cancer Research), University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.ORCID 0000-0003-1058-2107
Beate TimmermannWestdeutsches Protonentherapiezentrum Essen, University Hospital Essen, 45147 Essen, Germany.ORCID 0000-0003-2274-2008
Martin StuschkeInstitute of Medical Radiation Biology, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.ORCID 0000-0001-6836-0940
George IliakisDepartment of Radiation Therapy, Division of Experimental Radiation Biology, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.ORCID 0000-0002-1152-5342

Funding

Bundesministerium für Forschung, Technologie und Raumfahrt 02NUK037BBundesministerium für Forschung, Technologie und Raumfahrt 02NUK043BBundesministerium für Forschung, Technologie und Raumfahrt 02NUK054BBundesministerium für Forschung, Technologie und Raumfahrt 50WB1836Bundesministerium für Forschung, Technologie und Raumfahrt 50WB2118Deutsche Forschungsgemeinschaft (DFG) GRK1739Deutsche Forschungsgemeinschaft (DFG) IL51.10Deutsche Forschungsgemeinschaft (DFG) IL51.11German Academic Exchange Service 57515880
6 · The paper itself

Abstract

Protons are conventionally regarded as a low-linear energy transfer (low-LET) radiation modality with a relative biological effectiveness (RBE) of 1.1, suggesting direct mechanistic similarity to X-rays in the underpinning biological effects. However, exposure to spread-out Bragg peak (SOBP) protons reveals instructive deviations from this assumption. Indeed, proton beams have a maximum LET of ~5 keV/µm but display reduced reliance on classical non-homologous end joining (c-NHEJ) as well as an increased dependence on homologous recombination (HR) and alternative end joining (alt-EJ). These features are well described in cells exposed to high-LET radiation and typically manifest between 100 and 150 keV/µm. We hypothesized that this apparent discrepancy reflects biological consequences of proton-beam properties that remain uncharacterized. In the present study, we outline exploratory experiments aiming at uncovering such mechanisms. We begin by investigating for both entrance and SOBP protons the dose-dependent engagement of HR we recently showed for X-rays. Consistent with our previous findings with X-rays, HR engagement after exposure to both types of proton beams declined with dose, from ~80% at 0.2 Gy to less than 20% at higher doses. RAD51/γH2AX foci ratios, reflecting HR engagement, were modestly higher following proton irradiation, in line with increased HR utilization. G

Indexed as

DNA End-Joining RepairHomologous RecombinationLinear Energy TransferProtonsProton TherapyA549 CellsHistonesHumansRad51 RecombinaseRadiation DosageH2AX protein, humanHistonesProtonsRad51 Recombinasealternative end joining (alt-EJ)classical non-homologous end joining (c-NHEJ)DNA double strand breaks (DSBs)homologous recombination (HR)ionizing radiation (IR)linear energy transfer (LET)proton radiationrelative biological effectiveness (RBE)structural chromosomal abnormalities (SCAs)

Identifiers

PMID41511369
PMCPMC12785619

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.